This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients
Scientific Reports Open Access 15 July 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Verheyden S, Demanet C . NK cell receptors and their ligands in leukemia. Leukemia 2008; 22: 249–257.
Maxwell LD, Wallace A, Middleton D, Curran MD . A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey. Tissue Antigens 2002; 60: 254–258.
Verheyden S, Bernier M, Demanet C . Identification of natural killer cell receptor phenotypes associated with leukemia. Leukemia 2004; 18: 2002–2007.
Verheyden S, Demanet C . Susceptibility to myeloid and lymphoid leukemia is mediated by distinct inhibitory KIR-HLA ligand interactions. Leukemia 2006; 20: 1437–1438.
Gomez-Lozano N, Vilches C . Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers: an update. Tissue Antigens 2002; 59: 184–193.
Luszczek W, Majorczyk E, Nowak I, Pawlik A, Jasek M, Wisniewski A et al. Inhibitory and activatory KIR gene frequencies in the Polish population. Int J Immunogenet 2006; 33: 167–170.
Katz G, Markel G, Mizrahi S, Arnon TI, Mandelboim O . Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4. J Immunol 2001; 166: 7260–7267.
Katz G, Gazit R, Arnon TI, Gonen-Gross T, Tarcic G, Markel G et al. MHC class I-independent recognition of NK-activating receptor KIR2DS4. J Immunol 2004; 173: 1819–1825.
Acknowledgements
The study was supported by the Grant no. 2 PO5B 155 28 from the Polish Ministry of Science and Higher Education.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Giebel, S., Nowak, I., Wojnar, J. et al. Association of KIR2DS4 and its variant KIR1D with leukemia. Leukemia 22, 2129–2130 (2008). https://doi.org/10.1038/leu.2008.108
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2008.108
This article is cited by
-
Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients
Scientific Reports (2023)
-
Diversity of KIRs in invasive breast cancer patients and healthy controls along with the clinical significance in ER/PR/HER2+ patients
Genes & Immunity (2020)
-
Killer-cell immunoglobulin-like receptor genes and ligands and their role in hematologic malignancies
Cancer Immunology, Immunotherapy (2016)
-
KIR-HLA profiling shows presence of higher frequencies of strong inhibitory KIR-ligands among prognostically poor risk AML patients
Immunogenetics (2016)
-
Novel insights in the genomic organization and hotspots of recombination in the human KIR locus through analysis of intergenic regions
Genes & Immunity (2015)